Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Specimen Handling 34 Carboplatin 32 pembrolizumab 28 Pemetrexed 27 Magnetic Resonance Spectroscopy 27 Cisplatin 22 Paclitaxel 15 Gemcitabine 13 durvalumab 12 Docetaxel 12 osimertinib 11 Nivolumab 11 atezolizumab 8 Immunoglobulin G 8 Disulfides 8 Taxes 7 Etoposide 7 130-nm albumin-bound paclitaxel 7 Radiotherapy 6 Radiosurgery 6 Radiation 6 Platinum 6 Cetuximab 6 Biopsy 6 X-Rays 5 1,2-diaminocyclohexaneplatinum II citrate 5 Ramucirumab 4 Observation 4 Irinotecan 4 Albumin-Bound Paclitaxel 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × aumolertinib × 30 days × Clear all

NCT04841811 2026-05-22

APPROACH

Guangdong Association of Clinical Trials

Phase 3 Active not recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡